Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameVeterinary Medicine Advisory CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2013Committee Number1042
Original Establishment Date11/28/1990Committee StatusTerminated
Actual Termination Date9/24/2013Committee URLhttp://www.fda.gov/AdvisoryCommittees/Committee...
New Committee This FYNoPresidential Appointments*No
Terminated This FYYesMax Number of Members*13
Current Charter Date4/24/2012Designated Fed Officer Position Title*Executive Secretary
Date Of Renewal Charter4/24/2014Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Aleta
Exempt From Renewal*NoDesignated Federal Officer Middle NameM.
Specific Termination AuthorityDesignated Federal Officer Last Name*Sindelar
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixRN
Specific Establishment Authority*21 U.S.C. 394Designated Federal Officer Phone*(240) 276-9004
Effective Date Of Authority*11/28/1990Designated Federal Officer Fax*240-276-9020
Exempt From EO 13875 Discretionary Cmte Designated Federal Officer Email*aleta.sindelar@fda.hhs.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNo
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Veterinary Medicine Advisory Committee advises the Commissioner in discharging their responsibilities as they relate to assuring safe and effective drugs, feeds and feed additives, and devices for animal use, and, as required, any other product for which the Food and Drug Administration has regulatory responsibility.
How is membership balanced?*The Committee consists of a core of 13 voting members including the Chair, who are knowledgeable of the issues related to the Committee’s function. Members and the Chair are selected by the Commissioner, or designee, from among authorities knowledgeable in the fields of companion animal medicine, food animal medicine, avian medicine, microbiology, biometrics, toxicology, pathology, pharmacology, animal science, chemistry, public health/epidemiology and minor species/minor use veterinary medicine. One member is technically qualified and identified with consumer interests. The committee may also include one non-voting member who is identified with industry interests.
How frequent & relevant are cmte mtgs?*The VMAC did not meet during FY2013. The VMAC was terminated September 24, 2013.
Why advice can't be obtained elsewhere?*Members of the committee are drawn from academia, research, and/or clinical practice. Their advice and input lends credibility to regulatory decisions and helps those decisions stand up to intense public scrutiny. The alternate means of obtaining this advice would involve the recruitment of large numbers of scientists on a full-time basis at maximum rates of compensation.
Why close or partially close meetings?There were no closed meetings to report in FY-13. The committee was terminated September 24, 2013.
Recommendation RemarksNo reports required for FY-13.

Although this committee did not meet in FY-13, considerable time was devoted to finding our whether or not the committee should be terminated. It was found on September 24, 2013 that the agency no longer needed the committee so it was terminated.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsYes
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherYes
Outcome Increased Customer SatisfactionYesAction CommentFDA approves or chooses not to approve an investigational new medical or food product.
Outcome Implement Laws/Reg RequirementsYesGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentThe utilization of the Veterinary Medicine Advisory Committee enables the Agency to obtain required and frequently scarce professional services from medical and scientific experts not otherwise available to the Agency; and to obtain the services of these experts only on an as needed basis rather than on a full time basis. The service of the committee resulted in advice for the improvement of the public health, for which it is difficult to assign a financial value.Grants Review CommentNA
Number Of Recommendations*6Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe committee met six times since FY2003 to discuss and make a collective recommendation on six separate issues. Each meeting transcript can be found at http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/VeterinaryMedicineAdvisoryCommittee/default.htmAccess Agency WebsiteYes
% of Recs Fully Implemented*80.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThe function of an advisory committee is purely advisory in nature. Although the FDA most often accepts the recommendations from its committees, the advice is purely advisory in nature, and therefore, the Agency has the option of not implementing the advice.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*10.00%Access PublicationsYes
% of Recs Partially Implemented CommentThe function of an advisory committee is purely advisory in nature. Although the FDA most often accepts the recommendations from its committees, the advice is purely advisory in nature, and therefore, the Agency has the option of not implementing the advice.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback CommentIt usually does. Product approval issues are first released to the sponsor. When appropriate, information is made available to the public. Actions related to guidance documents or other general matters issues are available publicly when implemented.Narrative Description*FDA’s strategic priorities in responding to the public health challenges of the 21st century are to advance regulatory science and innovation; strengthen the safety and integrity of the global supply chain; strengthen compliance and enforcement activities to support public health; expand efforts to meet the needs of special populations; advance medical countermeasures and emergency preparedness; advance food safety and nutrition; promote public health by advancing the safety and effectiveness of medical products; establish an effective tobacco regulation, prevention, and control program; and manage for organizational excellence and accountability. The Veterinary Medicine Advisory Committee supports FDA's strategic priorities by advising the Commissioner or designee in discharging responsibilities as they relate to helping to ensure public and animal health by approving safe and effective animal drugs and, as required, any other product for which the Food and Drug Administration has regulatory responsibility.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$0.00Est Payments to Non-Fed Members Next FY*$0.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$0.00
Payments to Federal Staff*$51,535.00Estimated Payments to Federal Staff*$0.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$0.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$12,884.00Est. Other Costs Next FY*$50,649.00
Total Costs$64,419.00Est. Total Next FY*$50,649.00
Federal Staff Support (FTE)*0.30Est. Fed Staff Support Next FY*0.30
Hide Section - Custom Links

Custom Links

     Committee Level Reports               
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-006707Veterinary Medicine Advisory Committee2012
 COM-008305Veterinary Medicine Advisory Committee2011
 COM-009027Veterinary Medicine Advisory Committee2010
 COM-010223Veterinary Medicine Advisory Committee2009
 COM-010961Veterinary Medicine Advisory Committee2008
 COM-012236Veterinary Medicine Advisory Committee2007
 COM-012572Veterinary Medicine Advisory Committee2006
 COM-013737Veterinary Medicine Advisory Committee2005
 COM-014531Veterinary Medicine Advisory Committee2004
 COM-015916Veterinary Medicine Advisory Committee2003
 COM-016533Veterinary Medicine Advisory Committee2002
 COM-017628Veterinary Medicine Advisory Committee2001
 COM-018537Veterinary Medicine Advisory Committee2000
 COM-019578Veterinary Medicine Advisory Committee1999
 COM-020655Veterinary Medicine Advisory Committee1998
 COM-021402Veterinary Medicine Advisory Committee1997